Hims & Hers Health (HIMS) Notes Payables (2019)
Hims & Hers Health (HIMS) posted Notes Payables of $61720.0 for Q3 2019.
Hims & Hers Health (HIMS) Notes Payables (2019) Analysis & Trends
Hims & Hers Health has reported Notes Payables for 1 years, with the latest figure at $61720.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Hims & Hers Health | 7.49 Bn | 6.65 Bn | 480.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 61,720.00 |